What increased investment means for rare disease clinical trials
Dr Julie Vallortigara from Ataxia UK explores how pharma investment is tackling the challenges in the rare disease space and creating...
KNect365 Life Sciences is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.